Ticker Sage

Insider digest · BMY

Bristol Myers Squibb insider filings, Oct 5, 2026

Bristol Myers Squibb insiders filed 1 routine Form 4 report on Oct 5, 2026: tax withholding, exercises. None of them was a purchase or a sale in the market. This page groups them in one place; each row links to the filing note, and each number links to the Form 4 itself.

What the codes mean: how to read a Form 4 · stock-based compensation.

Shares withheld for taxes

Shares the company kept back to cover taxes (or the exercise price) when awards vested. This is not a sale in the market. Total for the day: 2,332 shares or units, worth about $142,602 at the prices reported.

PersonCodeSecuritySharesPriceValueHeld after
Cari Gallman · EVP, General CounselFCommon Stock, $0.10 par value2,332$61.15$142,60215,876

Exercises and conversions

Options exercised or units converted into shares. Total for the day: 9,118 shares or units.

PersonCodeSecuritySharesPriceValueHeld after
Cari Gallman · EVP, General CounselMCommon Stock, $0.10 par value4,559––18,208
Cari Gallman · EVP, General CounselMRestricted Stock Units4,559––0

The filings

Bristol Myers Squibb company file → · All Bristol Myers Squibb filings notes

Disclosures

Editor holdings in BMY
The editor holds no position in Bristol Myers Squibb (BMY). As of Nov 11, 2026.
Compensation
Nobody paid for this page. No affiliate links.

A summary of public filings for general education, the same for every reader. Not a recommendation to buy, sell or hold BMY.